Lawrence Hineline
Director of Finance/CFO bei INTRA-CELLULAR THERAPIES, INC.
Vermögen: - $ am 31.03.2024
Profil
Lawrence J.
Hineline is currently the Chief Financial Officer, Treasurer & SVP-Finance at Intra-Cellular Therapies, Inc. since 2013 and the Chief Financial Officer, Secretary & VP at ITI, Inc. (New York) since 2002.
Previously, he held the position of Vice President-Finance at North American Vaccine, Inc. from 1989 to 2000, Chief Financial Officer, Secretary & VP at Intra-Cellular Therapies, Inc. in 2013, Principal at Deloitte & Touche LLP in 1984, and Chief Financial Officer & Vice President-Finance at Functional Genetics, Inc. from 2000 to 2003.
Mr. Hineline obtained his undergraduate degree from the University of Maryland and the University of Maryland Baltimore County.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
11.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Lawrence Hineline
Unternehmen | Position | Beginn |
---|---|---|
INTRA-CELLULAR THERAPIES, INC. | Director of Finance/CFO | 05.09.2013 |
ITI, Inc. (New York) | Director of Finance/CFO | 01.06.2002 |
Ehemalige bekannte Positionen von Lawrence Hineline
Unternehmen | Position | Ende |
---|---|---|
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Director of Finance/CFO | 26.09.2013 |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Director of Finance/CFO | 01.11.2003 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Director of Finance/CFO | 01.01.2000 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1984 |
Ausbildung von Lawrence Hineline
University of Maryland | Undergraduate Degree |
University of Maryland Baltimore County | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Commercial Services |
ITI, Inc. (New York) |